Gladstone NOW: The Campaign Join Us on the Journey✕
Nearly half of all babies born with Down syndrome face congenital heart defects, often involving serious malformations that require surgery in the first months of life.
Using stem cells, gene editing, and AI, a team of scientists at Gladstone Institutes identified one gene that plays a key role in the heart defects seen in Down syndrome. Then, by reducing the levels of this gene in mice, they were able to fix the problem and restore normal heart development.
In this video, Deepak Srivastava, Katie Pollard, and Sanjeev Ranade explain what they found and how their work could pave the way for treatments to help prevent heart malformations in people with Down syndrome and related heart defects.
Read more about this study, which was published in the journal Nature.
Gladstone NOW: The Campaign
Join Us On The Journey
In this video, Katie Pollard and Deepak Srivastava explain how Gladstone scientists are combining AI models with novel tools in the lab to finally decode the entire human genome.
Gladstone Experts Pollard Lab Srivastava Lab AIIn this video, Nadia Roan and Ashley George explain how they uncovered a new path toward long-term health without the need for daily HIV pills.
Gladstone Experts Research (Publication) HIV/AIDS Infectious Disease Roan LabFrom fundamental insights to translational advances, here’s how Gladstone researchers moved science forward in 2025.
Gladstone Experts Alzheimer’s Disease Autoimmune Diseases COVID-19 Neurological Disease Genomic Immunology Cardiovascular Disease Data Science and Biotechnology Infectious Disease Conklin Lab